MX2021013507A - Proceso para la preparacion de inhibidores del canal de cloruro ciec-1. - Google Patents
Proceso para la preparacion de inhibidores del canal de cloruro ciec-1.Info
- Publication number
- MX2021013507A MX2021013507A MX2021013507A MX2021013507A MX2021013507A MX 2021013507 A MX2021013507 A MX 2021013507A MX 2021013507 A MX2021013507 A MX 2021013507A MX 2021013507 A MX2021013507 A MX 2021013507A MX 2021013507 A MX2021013507 A MX 2021013507A
- Authority
- MX
- Mexico
- Prior art keywords
- ciec
- chloride channel
- preparation
- channel inhibitors
- formula
- Prior art date
Links
- 108010062745 Chloride Channels Proteins 0.000 title abstract 2
- 102000011045 Chloride Channels Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000001311 chemical methods and process Methods 0.000 abstract 1
- 101150052500 cic-1 gene Proteins 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19181262 | 2019-06-19 | ||
| PCT/EP2020/067065 WO2020254554A1 (en) | 2019-06-19 | 2020-06-19 | Process for the preparation of clc-1 chloride channel inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021013507A true MX2021013507A (es) | 2021-12-10 |
Family
ID=66999603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021013507A MX2021013507A (es) | 2019-06-19 | 2020-06-19 | Proceso para la preparacion de inhibidores del canal de cloruro ciec-1. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US12221425B2 (https=) |
| EP (1) | EP3986878B1 (https=) |
| JP (1) | JP7595945B2 (https=) |
| KR (1) | KR102900834B1 (https=) |
| CN (1) | CN113993852B (https=) |
| AR (1) | AR119198A1 (https=) |
| AU (1) | AU2020298092B2 (https=) |
| BR (1) | BR112021025588A2 (https=) |
| CA (1) | CA3137672A1 (https=) |
| ES (1) | ES3000437T3 (https=) |
| HU (1) | HUE069104T2 (https=) |
| IL (1) | IL287901B2 (https=) |
| MX (1) | MX2021013507A (https=) |
| PL (1) | PL3986878T3 (https=) |
| SG (1) | SG11202111122RA (https=) |
| TW (1) | TWI849152B (https=) |
| WO (1) | WO2020254554A1 (https=) |
| ZA (1) | ZA202107653B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4593829A1 (en) | 2022-09-30 | 2025-08-06 | NMD Pharma A/S | Compositions and methods for treating myasthenia gravis |
| WO2024180199A1 (en) | 2023-03-02 | 2024-09-06 | Nmd Pharma A/S | Compositions and methods for treating charcot–marie–tooth disease |
| JP2026508357A (ja) | 2023-03-02 | 2026-03-10 | エヌエムディー ファーマ エー／エス | 脊髄性筋萎縮症を処置するための組成物及び方法 |
| EP4731200A1 (en) | 2023-06-20 | 2026-04-29 | NMD Pharma A/S | Clc-1 inhibitors for use in the treatment of multiple sclerosis and neuromuscular diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301010D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| GB0422057D0 (en) * | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| GB0524428D0 (en) * | 2005-11-30 | 2006-01-11 | 7Tm Pharma As | Medicinal use of receptor ligands |
| WO2009097970A1 (de) * | 2008-02-05 | 2009-08-13 | Sanofi-Aventis | Triazolopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel |
| JP2015505560A (ja) * | 2012-02-03 | 2015-02-23 | ゾエティス・エルエルシー | 抗寄生虫薬としてのキラルイソオキサゾリンアゼチジン誘導体の製造法 |
| MX389242B (es) | 2015-06-15 | 2025-03-20 | Nmd Pharma As | Compuestos para su uso en el tratamiento de trastornos neuromusculares |
| US10385028B2 (en) * | 2017-12-14 | 2019-08-20 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| TWI780281B (zh) | 2017-12-14 | 2022-10-11 | 丹麥商Ｎｍｄ藥品公司 | 用於治療神經肌肉病症的化合物 |
-
2020
- 2020-06-19 BR BR112021025588A patent/BR112021025588A2/pt unknown
- 2020-06-19 IL IL287901A patent/IL287901B2/en unknown
- 2020-06-19 ES ES20734157T patent/ES3000437T3/es active Active
- 2020-06-19 SG SG11202111122RA patent/SG11202111122RA/en unknown
- 2020-06-19 EP EP20734157.9A patent/EP3986878B1/en active Active
- 2020-06-19 CN CN202080043796.2A patent/CN113993852B/zh active Active
- 2020-06-19 HU HUE20734157A patent/HUE069104T2/hu unknown
- 2020-06-19 TW TW109120910A patent/TWI849152B/zh active
- 2020-06-19 US US17/619,312 patent/US12221425B2/en active Active
- 2020-06-19 JP JP2021569300A patent/JP7595945B2/ja active Active
- 2020-06-19 MX MX2021013507A patent/MX2021013507A/es unknown
- 2020-06-19 CA CA3137672A patent/CA3137672A1/en active Pending
- 2020-06-19 AR ARP200101735A patent/AR119198A1/es unknown
- 2020-06-19 AU AU2020298092A patent/AU2020298092B2/en active Active
- 2020-06-19 KR KR1020217037880A patent/KR102900834B1/ko active Active
- 2020-06-19 WO PCT/EP2020/067065 patent/WO2020254554A1/en not_active Ceased
- 2020-06-19 PL PL20734157.9T patent/PL3986878T3/pl unknown
-
2021
- 2021-10-11 ZA ZA2021/07653A patent/ZA202107653B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3986878A1 (en) | 2022-04-27 |
| HUE069104T2 (hu) | 2025-02-28 |
| BR112021025588A2 (pt) | 2022-02-01 |
| IL287901A (en) | 2022-01-01 |
| PL3986878T3 (pl) | 2025-01-20 |
| EP3986878C0 (en) | 2024-09-25 |
| CN113993852A (zh) | 2022-01-28 |
| TWI849152B (zh) | 2024-07-21 |
| US12221425B2 (en) | 2025-02-11 |
| KR102900834B1 (ko) | 2025-12-16 |
| AU2020298092A1 (en) | 2021-11-18 |
| CN113993852B (zh) | 2024-12-17 |
| SG11202111122RA (en) | 2021-11-29 |
| TW202115003A (zh) | 2021-04-16 |
| AU2020298092A8 (en) | 2025-04-24 |
| IL287901B2 (en) | 2025-02-01 |
| CA3137672A1 (en) | 2020-12-24 |
| WO2020254554A1 (en) | 2020-12-24 |
| ES3000437T3 (en) | 2025-02-28 |
| JP2022537493A (ja) | 2022-08-26 |
| JP7595945B2 (ja) | 2024-12-09 |
| IL287901B1 (en) | 2024-10-01 |
| AU2020298092B2 (en) | 2025-09-25 |
| ZA202107653B (en) | 2023-05-31 |
| EP3986878B1 (en) | 2024-09-25 |
| KR20220022895A (ko) | 2022-02-28 |
| AR119198A1 (es) | 2021-12-01 |
| US20220298124A1 (en) | 2022-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR132627A2 (es) | Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos | |
| MX2025002980A (es) | Compuestos de anillo fusionado | |
| MX2021013507A (es) | Proceso para la preparacion de inhibidores del canal de cloruro ciec-1. | |
| EA201692114A1 (ru) | Замещенные дигидроизохинолиноновые соединения | |
| MX388682B (es) | Compuestos agonistas de gpr119 y metodo para tratar enfermedades y afecciones mediado a traves de gpr119. | |
| MX379920B (es) | Compuestos agonistas de gpr119 y metodo para tratar enfermedades y afecciones mediado a traves de gpr119. | |
| NZ777370A (en) | Bicyclic derivatives | |
| MX377277B (es) | Derivados de fenoximetilo. | |
| MX2022005708A (es) | Sintesis mejorada del compuesto inhibidor de g12c de kras. | |
| EA201691302A1 (ru) | Новые гетероциклические соединения | |
| MX2021007540A (es) | Derivados biciclicos. | |
| MX372962B (es) | Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca). | |
| BR112018001017A2 (pt) | inibidores do receptor de fator-1 de estimulação de colônia (csf-1r) | |
| PH12019502605A1 (en) | Glucuronide prodrugs of janus kinase inhibitors | |
| EA201591889A1 (ru) | 6-(5-гидрокси-1h-пиразол-1-ил)никотинамидные ингибиторы phd | |
| EA201692521A1 (ru) | Пиразольные соединения и их применение в качестве блокаторов кальциевых каналов т-типа | |
| MX394835B (es) | Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol. | |
| PH12019502093A1 (en) | Novel ester compounds, method for the production thereof and use thereof | |
| EA201790800A1 (ru) | Замещенные производные бензотиофенила в качестве агонистов gpr40 для лечения диабета ii типа | |
| EA201992360A1 (ru) | Кристаллические формы (s)-афоксоланера | |
| AR116790A1 (es) | PROCEDIMIENTO PARA LA PREPARACIÓN DE 3a-HIDROXI-5a-PREGNAN-20-ONA (BREXANOLONA) | |
| PH12018550165A1 (en) | An improved process for the preparation of butorphanol tartrate | |
| EA202090933A1 (ru) | Способ получения гербицидных соединений пиридазинона | |
| EA201691632A1 (ru) | Пиразины в качестве модуляторов gpr6 | |
| EA201790613A1 (ru) | Триазольные соединения в качестве блокаторов кальциевых каналов т-типа |